Both preclinical and clinical studies proved that blockade of PD-1 or PD-L1 inhibits tumor growth or delay progression in a broad spectrum of tumor types including solid and hematologic malignancies [31–35]. This evidence concerns the gene PDCD1 and neoplasm.